Topal A, Başak M. Evaluating the role of HER2-low versus HER2-0 status in predicting response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer. Eur Res J. 2025;11(5):858-867. doi:10.18621/eurj.1704067